{reportSlug=global-benign-prostatic-hyperplasia-treatment-market, reportId=165988, mktKeyword=Benign Prostatic Hyperplasia Treatment, cagr=0.00, publishDate=Feb 2021, priceOption2=6800, reportTitle=Benign Prostatic Hyperplasia Treatment Comprehensive Study by Type (Medications (Alpha-blockers, 5-alpha reductase inhibitors, Combination drug therapy and Tadalafil (Cialis)), Minimally invasive or surgical therapy, Laser therapy, Embolization, Others), End-user (Hospitals, Clinics, Ambulatory Surgical Centres), Diagnosis (Digital Rectal Exam, Urine Test, Blood Test, Prostate-Specific Antigen (PSA) Blood Test) Players and Region - Global Market Outlook to 2026, baseYr=2021, totalTableFig=216, priceOption1=3750, forecastYr=2027, noOfPages=239, reportKey=165500, breadcrum=Global Benign Prostatic Hyperplasia Treatment Market}
We do not share your information with anyone. However, we may send you
emails based on your report interest from time to time. You may contact
us at any time to opt-out.
Select User Access Type
Key Highlights of Report
Feb 2021
239 Pages
54 Tables
Base Year: 2021Coverage: 15+ Companies; 18
Countries